Nexus Venture Partners — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Triomicstriomics.comin𝕏Dec 2022 · $22M
Triomics builds AI systems for oncology teams that read full patient records and produce structured, auditable outputs for trial matching, visit preparation, and data curation.
AI & Machine LearningHealthtechMedical DevicesNew York City, US
Sarim Khan(Founder)inHrituraj Singh(Founder)inDevtosh Kumar Khare(Director)
BoardSameer Brij Verma(Director)Sajjan Rajpurohit(Director)
Co-investorsBattery VenturesY CombinatorLightspeed Venture PartnersOncology VenturesGeneral Catalyst
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.